149 related articles for article (PubMed ID: 3124282)
1. [Immune disorders in hemophiliac patients].
Kachorovskiĭ BV; Loginskiĭ VE; Vygovskaia IaI; Rudenko VP
Ter Arkh; 1987; 59(10):81-5. PubMed ID: 3124282
[TBL] [Abstract][Full Text] [Related]
2. T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
Lechner K; Niessner H; Bettelheim P; Deutsch E; Fasching I; Fuhrmann M; Hinterberger W; Korninger C; Neumann E; Liszka K
Thromb Haemost; 1983 Aug; 50(2):552-6. PubMed ID: 6314582
[TBL] [Abstract][Full Text] [Related]
3. [Apropos of emergency management of hemophiliac patients with suspected hemorrhage].
Sultan Y
Presse Med; 1999 Mar; 28(11):595-6. PubMed ID: 10214385
[No Abstract] [Full Text] [Related]
4. [The effect of specific transfusion therapy on the level of circulating immune complexes in hemophilia patients].
Andreeva TA; Fedorova ZD; Khanin TM; Klimova NI
Ter Arkh; 1991; 63(7):50-3. PubMed ID: 1788808
[TBL] [Abstract][Full Text] [Related]
5. Transfusion support for haemophiliacs.
Allain JP
Clin Haematol; 1984 Feb; 13(1):99-117. PubMed ID: 6426835
[No Abstract] [Full Text] [Related]
6. Sequential clinical and immunologic abnormalities in hemophiliacs.
Goldsmith JM; Kalish SB; Green D; Chmiel JS; Wallemark CB; Phair JP
Arch Intern Med; 1985 Mar; 145(3):431-4. PubMed ID: 3919666
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of typical immune reactions in myocardial infarction].
Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
[TBL] [Abstract][Full Text] [Related]
8. [Changes in the lymphocyte regulatory subpopulations in hemophilia patients resulting from immunocorrective therapy].
Pliushch OP; Kopylov KG; Bulycheva TI; Novikova MN
Ter Arkh; 1997; 69(7):40-2. PubMed ID: 9424756
[No Abstract] [Full Text] [Related]
9. [Emergency management of hemophiliac patients with suspected hemorrhage. National Agency of Accreditation and Evaluation in Health (ANAES)].
Presse Med; 1999 Mar; 28(11):591-5. PubMed ID: 10214384
[No Abstract] [Full Text] [Related]
10. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the composition and properties of the joint contents in hemophilic arthropathies during local invasive therapy].
Barkagan ZS; Chantsev AV; Usynin VV; Liashenko LA
Ter Arkh; 1994; 66(7):61-5. PubMed ID: 7985133
[TBL] [Abstract][Full Text] [Related]
12. Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
Berntorp E; Astermark J; Carlborg E
Haematologica; 2000 Oct; 85(10 Suppl):48-50; discussion 50-1. PubMed ID: 11187871
[TBL] [Abstract][Full Text] [Related]
13. [The importance of studying the joint contents in diagnosing secondary immune disorders and in assessing therapeutic efficacy in hemophilic arthropathies].
Barkagan ZS; Chantsev AV; Goncharov PM
Ter Arkh; 1994; 66(12):54-6. PubMed ID: 7900047
[No Abstract] [Full Text] [Related]
14. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
Menitove JE; Aster RH; Casper JT; Lauer SJ; Gottschall JL; Williams JE; Gill JC; Wheeler DV; Piaskowski V; Kirchner P; Montgomery RR
N Engl J Med; 1983 Jan; 308(2):83-6. PubMed ID: 6401196
[No Abstract] [Full Text] [Related]
15. Immunological alterations in haemophiliacs treated with lyophilized Factor VIII cryoprecipitate from volunteer donors.
Ceuppens JL; Vermylen J; Colaert J; Desmyter J; Gautama K; Stevens E; The AL; Vanham G; Vermylen C; Verstraete M
Thromb Haemost; 1984 Apr; 51(2):207-11. PubMed ID: 6429883
[TBL] [Abstract][Full Text] [Related]
16. Factor VIII inhibitor treatment. Immune tolerance.
Nilsson IM
Semin Hematol; 1994 Apr; 31(2 Suppl 4):44-8. PubMed ID: 7939775
[No Abstract] [Full Text] [Related]
17. [Renal hemorrhages in hemophilia in children].
Alekseenko IF; Mokina VP
Zdravookhr Kirg; 1979; (3):48-51. PubMed ID: 38600
[No Abstract] [Full Text] [Related]
18. [Experience from the Hemophilia Clinic. 3. Intramuscular hemorrhages in hemophilia].
van Creveld S; Mochtar IA; van Donk H
Ned Tijdschr Geneeskd; 1970 Apr; 114(17):719-22. PubMed ID: 5444639
[No Abstract] [Full Text] [Related]
19. [Characterization of immune disorders in hemophiliac patients with the identification of inhibitor-dependence in replacement transfusion therapy].
Rudenko VP; Stasyshyn OV; Lebed' HB; Orlyk VV; Lohins'kyĭ VIe
Lik Sprava; 2001; (3):39-43. PubMed ID: 11560024
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of immunologic disorders in patients with acute destructive pancreatitis].
Tarasenko VS; Kubyshkin VA; Smoliagin AI; Popova EV; Shefer AV
Khirurgiia (Mosk); 2001; (4):31-4. PubMed ID: 11490488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
